RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Shandong Weigao Group Medical Polymer Co Stock

Shandong Weigao Group Medical Polymer Co Revenue 2024

Shandong Weigao Group Medical Polymer Co Revenue

14.4 B CNY

Ticker

1066.HK

ISIN

CNE100000171

WKN

A0M4WA

In 2024, Shandong Weigao Group Medical Polymer Co's sales reached 14.4 B CNY, a 8.81% difference from the 13.23 B CNY sales recorded in the previous year.

The Shandong Weigao Group Medical Polymer Co Revenue history

YEARREVENUE (undefined CNY)GROSS MARGIN (%)
2026e16.6439,72
2025e15.5242,60
2024e14.445,92
202313.2349,97
202213.7553,05
202113.2155,61
202011.6255,92
201910.3862,73
20188.8161,18
20176.2963,45
20165.6263,66
20155.9259,40
20145.2858,82
20134.6159,11
20123.6957,26
20113.1855,34
20102.4655,21
20091.8853,30
20081.5150,07
20071.145,69
20060.7942,61
20050.5741,11
20040.4139,97

Shandong Weigao Group Medical Polymer Co Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Shandong Weigao Group Medical Polymer Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Shandong Weigao Group Medical Polymer Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Shandong Weigao Group Medical Polymer Co’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Shandong Weigao Group Medical Polymer Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Shandong Weigao Group Medical Polymer Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Shandong Weigao Group Medical Polymer Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Shandong Weigao Group Medical Polymer Co’s growth potential.

Shandong Weigao Group Medical Polymer Co Revenue, EBIT and net profit per share

DateShandong Weigao Group Medical Polymer Co RevenueShandong Weigao Group Medical Polymer Co EBITShandong Weigao Group Medical Polymer Co Net Income
2026e16.64 B CNY3.12 B CNY2.66 B CNY
2025e15.52 B CNY2.87 B CNY2.43 B CNY
2024e14.4 B CNY2.62 B CNY2.21 B CNY
202313.23 B CNY2.35 B CNY2 B CNY
202213.75 B CNY3.19 B CNY2.76 B CNY
202113.21 B CNY3.1 B CNY2.28 B CNY
202011.62 B CNY2.74 B CNY2.09 B CNY
201910.38 B CNY2.44 B CNY1.85 B CNY
20188.81 B CNY1.84 B CNY1.47 B CNY
20176.29 B CNY1.47 B CNY1.73 B CNY
20165.62 B CNY1.17 B CNY1.11 B CNY
20155.92 B CNY1.32 B CNY1.11 B CNY
20145.28 B CNY1.16 B CNY1.08 B CNY
20134.61 B CNY1.09 B CNY388 M CNY
20123.69 B CNY912.2 M CNY996.5 M CNY
20113.18 B CNY899.4 M CNY3.59 B CNY
20102.46 B CNY691.7 M CNY799.1 M CNY
20091.88 B CNY563.8 M CNY633.9 M CNY
20081.51 B CNY489.9 M CNY482.4 M CNY
20071.1 B CNY291 M CNY308.1 M CNY
2006786.9 M CNY178.4 M CNY170.9 M CNY
2005570 M CNY121.6 M CNY101.2 M CNY
2004407.8 M CNY81.7 M CNY65.9 M CNY

Shandong Weigao Group Medical Polymer Co stock margins

The Shandong Weigao Group Medical Polymer Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Shandong Weigao Group Medical Polymer Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Shandong Weigao Group Medical Polymer Co.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Shandong Weigao Group Medical Polymer Co's sales revenue. A higher gross margin percentage indicates that the Shandong Weigao Group Medical Polymer Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Shandong Weigao Group Medical Polymer Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Shandong Weigao Group Medical Polymer Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Shandong Weigao Group Medical Polymer Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Shandong Weigao Group Medical Polymer Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Shandong Weigao Group Medical Polymer Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Shandong Weigao Group Medical Polymer Co Margin History

Shandong Weigao Group Medical Polymer Co Gross marginShandong Weigao Group Medical Polymer Co Profit marginShandong Weigao Group Medical Polymer Co EBIT marginShandong Weigao Group Medical Polymer Co Profit margin
2026e49.97 %18.75 %15.99 %
2025e49.97 %18.51 %15.68 %
2024e49.97 %18.19 %15.33 %
202349.97 %17.77 %15.13 %
202253.05 %23.18 %20.11 %
202155.61 %23.48 %17.23 %
202055.92 %23.6 %17.95 %
201962.73 %23.54 %17.82 %
201861.18 %20.87 %16.72 %
201763.45 %23.43 %27.47 %
201663.66 %20.86 %19.68 %
201559.4 %22.32 %18.8 %
201458.82 %21.93 %20.56 %
201359.11 %23.66 %8.41 %
201257.26 %24.73 %27.01 %
201155.34 %28.28 %112.76 %
201055.21 %28.09 %32.45 %
200953.3 %30.01 %33.75 %
200850.07 %32.35 %31.85 %
200745.69 %26.57 %28.13 %
200642.61 %22.67 %21.72 %
200541.11 %21.33 %17.75 %
200439.97 %20.03 %16.16 %

Shandong Weigao Group Medical Polymer Co Aktienanalyse

What does Shandong Weigao Group Medical Polymer Co do?

Shandong Weigao Group Medical Polymer Co Ltd is a globally operating company with headquarters in Weihai, China. It was founded in 1988 and has been listed on the Hong Kong Stock Exchange since 2004. The company specializes in the production of medical polymer products and offers a wide range of products for various applications. Its business model is that of an integrated platform for research, development, manufacturing, and marketing of medical devices. Their customers include hospitals, medical practices, and distributors worldwide. The company's portfolio includes products in the areas of infusion, blood transfusion, dialysis, surgery, anesthesia, first aid, and diagnostics. Both disposable and reusable products are available. With its offering, the company aims to contribute to improving the quality of healthcare and providing better outcomes for patients. Shandong Weigao Group Medical Polymer Co Ltd is divided into three divisions: Medical Devices, Medical Consumables, and Biology. The Medical Devices division manufactures devices for use in anesthesia, surgery, resuscitation, and diagnostics. The Medical Consumables division includes products such as syringes, catheters, infusion and transfusion devices, disposable gloves, and wound dressings. The Biology division specializes in the development, manufacturing, and marketing of biopharmaceutical products, such as insulin. The company's history is characterized by rapid expansion and continuous growth. The focus on R&D has played an important role in this. Through the use of advanced technologies, the company has acquired a multitude of patents in both China and other countries. The company places a strong emphasis on quality assurance and has implemented a comprehensive quality control system. In addition, it aims to minimize its environmental impact and therefore operates according to the latest environmental standards. In recent years, the company has established an international presence and opened subsidiaries in Europe and the USA. This demonstrates the company's desire to grow internationally and offer its products in more and more countries. In summary, Shandong Weigao Group Medical Polymer Co Ltd is an innovative company specializing in the production of medical polymer products and biopharmaceutical products. It offers a wide range of products and is committed to a comprehensive quality control system and sustainability. With its international presence, the company aims to continue growing and offer its products worldwide. Shandong Weigao Group Medical Polymer Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Shandong Weigao Group Medical Polymer Co's Sales Figures

The sales figures of Shandong Weigao Group Medical Polymer Co originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Shandong Weigao Group Medical Polymer Co’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Shandong Weigao Group Medical Polymer Co's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Shandong Weigao Group Medical Polymer Co’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Shandong Weigao Group Medical Polymer Co stock

How much revenue did Shandong Weigao Group Medical Polymer Co generate this year?

Shandong Weigao Group Medical Polymer Co has achieved a revenue of 14.4 B CNY this year.

How much was the turnover of the company Shandong Weigao Group Medical Polymer Co compared to the previous year?

The revenue of Shandong Weigao Group Medical Polymer Co has increased by 8.81% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Shandong Weigao Group Medical Polymer Co?

The revenue of Shandong Weigao Group Medical Polymer Co is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Shandong Weigao Group Medical Polymer Co measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Shandong Weigao Group Medical Polymer Co so important for investors?

The revenue of Shandong Weigao Group Medical Polymer Co is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Shandong Weigao Group Medical Polymer Co pay?

Over the past 12 months, Shandong Weigao Group Medical Polymer Co paid a dividend of 0.25 CNY . This corresponds to a dividend yield of about 6.03 %. For the coming 12 months, Shandong Weigao Group Medical Polymer Co is expected to pay a dividend of 0.27 CNY.

What is the dividend yield of Shandong Weigao Group Medical Polymer Co?

The current dividend yield of Shandong Weigao Group Medical Polymer Co is 6.03 %.

When does Shandong Weigao Group Medical Polymer Co pay dividends?

Shandong Weigao Group Medical Polymer Co pays a quarterly dividend. This is distributed in the months of November, July, July, November.

How secure is the dividend of Shandong Weigao Group Medical Polymer Co?

Shandong Weigao Group Medical Polymer Co paid dividends every year for the past 23 years.

What is the dividend of Shandong Weigao Group Medical Polymer Co?

For the upcoming 12 months, dividends amounting to 0.27 CNY are expected. This corresponds to a dividend yield of 6.57 %.

In which sector is Shandong Weigao Group Medical Polymer Co located?

Shandong Weigao Group Medical Polymer Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Shandong Weigao Group Medical Polymer Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Shandong Weigao Group Medical Polymer Co from 11/22/2024 amounting to 0.092 CNY, you needed to have the stock in your portfolio before the ex-date on 10/18/2024.

When did Shandong Weigao Group Medical Polymer Co pay the last dividend?

The last dividend was paid out on 11/22/2024.

What was the dividend of Shandong Weigao Group Medical Polymer Co in the year 2023?

In the year 2023, Shandong Weigao Group Medical Polymer Co distributed 0.172 CNY as dividends.

In which currency does Shandong Weigao Group Medical Polymer Co pay out the dividend?

The dividends of Shandong Weigao Group Medical Polymer Co are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Shandong Weigao Group Medical Polymer Co

Our stock analysis for Shandong Weigao Group Medical Polymer Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Shandong Weigao Group Medical Polymer Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.